This website uses cookies to ensure you get the best experience on our website.
- Table of Contents
, No Gclids
Disease Info Card
Isovaleryl-coa Dehydrogenase Deficiency
Information about Isovaleryl-coa Dehydrogenase Deficiency: characteristics, related genes and pathways, plus antibodies you can use for research. This page is being enriched constantly, if you see some information you would like this page to include please send your suggestions to us.
Overview of Isovaleryl-coa Dehydrogenase Deficiency
Most recent studies have shown that Isovaleryl-coa Dehydrogenase Deficiency shares some biological mechanisms with acidemia, acidosis, comatose, encephalopathies, hyperammonemia, inborn-errors-of-metabolism, ketosis, maple-syrup-urine-disease, medium-chain-acyl-coenzyme-a-dehydrogenase-deficiency, metabolic-acidosis, metabolic-diseases, methylmalonic-acidemia, phenylketonurias, propionic-acidemia, vomiting.
Among the many pathways, these few ones have gauged particular interests from scientists studying Isovaleryl-coa Dehydrogenase Deficiency, and have been seen in publications frequently: Brain Development, Conjugation, Diuresis, Excretion, Fatty Acid Beta-oxidation, Fatty Acid Oxidation, Methylation, Myelination, Pathogenesis, Protein Processing, Rna Processing, Rna Splicing, Translation, Transport, Tricarboxylic Acid Cycle, Urea Cycle
Quite a number of genes have been found to play important roles in Isovaleryl-coa Dehydrogenase Deficiency, such as ACAA1, ACAA2, ACADS, AMY2A, AUH, BLOC1S6, C5, EPB42, HADHB, HMGCL, IVD, NBN, NME1, OTC, PRH1, TEAD2. See what Boster has to offer for the research of these genes by clicking the gene name links below and view a more detailed info card/product listing for that gene.
In a later update, we will include information such as current drugs and therapy solutions as well as on-going and past clinical trials for this disease. Plesae stay updated.